PlainRecalls

Viatris

Compiled from official public sources by the publisher.

2 recalls on record · Latest: Oct 6, 2021

Subscribe to new Viatris recalls (RSS)

Agency notice ledger

Federal filing book Viatris LIGHT-BOOK · SINGLE-AGENCY

#6,013 of 14,151 · 2 notices · 0.002% archive

  • BOOK 2 notices
  • RANK #6,013 of 14,151
  • SHARE 0.002% archive
  • AGENCY FDA Drug (2)
  • CAT drugs
  • CATS 1 category
  • LATEST Oct 6, 2021
  • PHOTO 3M Company

Nearest notice-volume peer: 3M Company (0 notice gap)

Viatris accounts for about 0.002% of the 104,423-notice archive on 2 distinct filings — a light share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

How Viatris compares to 14,151 recalling firms

Viatris ranks 6,013th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Viatris vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

2 6013th of 14151 higher than 8,037 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Viatris in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Viatris holds about 0.002% of archive notices alongside 2 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate Oct 6, 2021

Lyrica CR (pregabalin) extended release tablets, 330 mg, 30-count bottles, Rx only, Distributed by Parke-Davis Division of Pfizer Inc., NY, NY 10017, NDC 0071-1029-01
FDA Drug Low Sep 22, 2021

Candesartan Cilexetil Tablets, USP 16 mg, 30 count bottles, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 NDC 0378-3231-93

Viatris is a small archive contributor

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Frequently Asked Questions

How many federal recall notices name Viatris? ▼
PlainRecalls indexes 2 distinct federal recall events naming Viatris, aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Viatris sit among other recalling firms? ▼
Viatris ranks #6,013 of 14,151 by distinct recall-event count among 14,151 firms in this archive (57th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Viatris's notices? ▼
FDA Drug accounts for 2 of this firm's 2 indexed notices.
What product category dominates Viatris's filing book? ▼
Filings for Viatris span 1 product category, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Viatris: 2 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Viatris; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026